Eli Lilly and Incyte released positive initial data of their coronavirus treatment when combined with Gilead’s remdesivir and said they would seek emergency use authorization from the FDA.

The post Eli Lilly, Incyte Combine Covid Drug With Gilead's, Post Positive Data appeared first on Investor's Business Daily.